AA
HQL

AQR Arbitrage’s abrdn Life Sciences Investors HQL Stock Holding History

AQR Arbitrage’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-82,193
Closed -$1.04M – 420
2025
Q1 		$1.04M Sell
82,193
-106,232
-56% -$1.44M 0.02% 229
2024
Q4 		$2.47M Sell
188,425
-74,853
-28% -$1.08M 0.05% 220
2024
Q3 		$3.97M Sell
263,278
-73,922
-22% -$1.12M 0.09% 197
2024
Q2 		$4.78M Sell
337,200
-50,110
-13% -$678K 0.12% 166
2024
Q1 		$5.28M Buy
387,310
+3,079
+0.8% +$42.6K 0.18% 131
2023
Q4 		$5.17M Buy
384,231
+111,735
+41% +$1.37M 0.21% 126
2023
Q3 		$3.4M Buy
272,496
+128,933
+90% +$1.7M 0.15% 160
2023
Q2 		$1.94M Buy
143,563
+49,864
+53% +$688K 0.08% 257
2023
Q1 		$1.31M Buy
93,699
+39,988
+74% +$572K 0.04% 393
2022
Q4 		$763K Buy
53,711
+43,681
+436% +$633K 0.02% 550
2022
Q3 		$137K Buy
+10,030
New +$150K ﹤0.01% 787
2021
Q1 		– Sell
-58,795
Closed -$1.16M – 1157
2020
Q4 		$1.16M Sell
58,795
-10,876
-16% -$201K 0.04% 390
2020
Q3 		$1.23M Buy
69,671
+18,073
+35% +$324K 0.04% 280
2020
Q2 		$927K Buy
51,598
+22,690
+78% +$389K 0.04% 294
2020
Q1 		$433K Buy
28,908
+16,124
+126% +$264K 0.01% 353
2019
Q4 		$223K Hold
12,784
– – ﹤0.01% 405
2019
Q3 		$193K Buy
+12,784
New +$205K ﹤0.01% 404

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

AQR Arbitrage's HQL Position: Q2 2025 in Review

AQR Arbitrage sold out of abrdn Life Sciences Investors (HQL) in Q2 2025, closing a stake of 82,193 shares — an estimated $1.04M sold.

AQR Arbitrage first reported a position in HQL in Q3 2019 and held it in 17 quarters. The position peaked at $5.28M in Q1 2024. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2025.

  • AQR Arbitrage reported no remaining abrdn Life Sciences Investors position as of Q2 2025 after selling out during the quarter.
  • AQR Arbitrage sold 82,193 abrdn Life Sciences Investors shares in Q2 2025, an estimated $1.04M.
  • AQR Arbitrage first reported a position in abrdn Life Sciences Investors in Q3 2019 and held it in 17 quarters.
  • AQR Arbitrage's abrdn Life Sciences Investors position peaked at $5.28M in Q1 2024.
  • 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2025.

Based on AQR Arbitrage's 13F filing for Q2 2025, filed 14 Aug 2025.